Artemis Medicare Services Ltd. Reports Robust Q1 FY27 Performance

Consolidated Revenue: ₹287.32 crore
Consolidated PAT Growth (YoY): 48.3%

Reader Takeaway: Strong profit jump and expansion plans are positives, but new unit losses and potential dilution are watch points.

What just happened

Artemis Medicare Services Ltd. announced its financial results for the first quarter of FY27. The company reported a consolidated revenue of ₹287.32 crore, marking a 12.7% increase year-on-year. Earnings before interest, taxes, depreciation, and amortization (EBITDA) stood at ₹61.82 crore, with an EBITDA margin of 21.5%. Profit After Tax (PAT) saw a significant surge of 48.3% to ₹31.44 crore compared to the same period last year.

Why this matters

The strong growth in revenue and PAT indicates improved operational performance and profitability. The robust EBITDA margin suggests effective cost management and a favourable case mix. The company also shared details of its expansion strategy, including a multi-year capital expenditure plan and progress on key projects, which signals future growth potential.

The backstory

Artemis Medicare, a notable player in the healthcare sector, operates hospitals in Gurugram and has been expanding its presence. The company focuses on providing tertiary and quaternary care services. Recent performance has been driven by operational efficiencies and a growing patient base, including international patients.

What changes now

With the Q1 results, Artemis Medicare has demonstrated its ability to grow profitability. The approved QIP resolution of up to ₹700 crore provides financial flexibility for planned brownfield expansions and potential acquisitions. The operationalization of the Raipur facility and the upcoming Tower IV in Gurugram are set to increase bed capacity significantly.

Risks to watch

The new 300-bed Artemis Shanti Hospital in Raipur is expected to incur operating losses of around ₹20 crore during its 15-18 month ramp-up phase. Investors will also need to monitor the potential equity dilution from the planned QIP if it proceeds. The Raipur facility currently requires an intermediary for cashless insurance services, with direct empanelment anticipated in 8-10 weeks.

Peer comparison

While specific peer financial data for Q1 FY27 is not provided in the filing, Artemis Medicare's performance, particularly its PAT growth and EBITDA margins, suggests it is holding its own against other multi-specialty hospital chains in India. The company's focus on higher-margin tertiary and quaternary care is a common strategy among leading healthcare providers.

Context metrics (time-bound)

• Gurugram Hospital Occupancy: 65.7%
• Gurugram Average Revenue Per Occupied Bed (ARPOB): ₹85,690
• International patient mix: 27% in Q1, targeting 30% in Q2.

What to track next

Investors should closely track the ramp-up of the Raipur facility and its path to profitability. Monitoring the execution of the Tower IV expansion and the eventual quantum and use of funds from the QIP will be crucial. The company's ability to maintain its international patient mix and further improve EBITDA margins will also be key performance indicators.